We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+15.96%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.33B
AUM Growth
+$352M
Cap. Flow
+$348M
Cap. Flow %
14.93%
Top 10 Hldgs %
55.33%
Holding
157
New
17
Increased
46
Reduced
30
Closed
20

Top Buys

Rank Stock Value
1
HGV icon
Hilton Grand Vacations
HGV
+$38.8M
2
SLNO
Soleno Therapeutics
SLNO
+$34.1M
3
KROS icon
Keros Therapeutics
KROS
+$27.7M
4
SVC
Service Properties Trust
SVC
+$26.2M
5
FOXF icon
Fox Factory Holding Corp
FOXF
+$21.9M

Top Sells

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$30.7M
2
PTON icon
Peloton Interactive
PTON
+$24.4M
3
PWSC
PowerSchool Holdings, Inc.
PWSC
+$13.3M
4
BKSY icon
BlackSky Technology
BKSY
+$9.19M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$8.79M

Sector Composition

Rank Sector Weight
1 Healthcare 38.07%
2 Consumer Discretionary 9.17%
3 Communication Services 4.02%
4 Financials 3.76%
5 Industrials 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
51
Tango Therapeutics
TNGX
$4.51B
$8.67M 0.37%
+2,804,410
New +$13M
CNTA
52
DELISTED
Centessa Pharmaceuticals
CNTA
$8.59M 0.37%
512,647
– –
UNCY icon
53
Unicycive Therapeutics
UNCY
$138M
$8.25M 0.35%
1,039,199
+757,163
+268% +$4.19M
KRYS icon
54
PUT
Krystal Biotech
KRYS
$9.81B
$7.83M 0.34%
50,000
-3,900
-7% -$692K
MLYS icon
55
Mineralys Therapeutics
MLYS
$2.41B
$7.79M 0.33%
632,506
– –
ILPT
56
Industrial Logistics Properties Trust
ILPT
$583M
$7.69M 0.33%
2,107,893
+976,761
+86% +$3.77M
VMD icon
57
Viemed Healthcare
VMD
$355M
$7.5M 0.32%
935,122
-200,000
-18% -$1.74M
SNDX icon
58
Syndax Pharmaceuticals
SNDX
$1.82B
$7.41M 0.32%
560,532
+107,300
+24% +$1.84M
NKTR icon
59
Nektar Therapeutics
NKTR
$2.53B
$7.26M 0.31%
520,667
+246,667
+90% +$4.35M
SLN
60
Silence Therapeutics
SLN
$729M
$7.22M 0.31%
1,049,676
+849,676
+425% +$11M
IKT icon
61
Inhibikase Therapeutics
IKT
$386M
$7.12M 0.31%
+2,190,000
New +$5.46M
ASRT
62
DELISTED
Assertio
ASRT
$7.1M 0.3%
543,222
-53,334
-9% -$795K
CZR icon
63
CALL
Caesars Entertainment
CZR
$6.13B
$6.68M 0.29%
200,000
– –
COGT icon
64
Cogent Biosciences
COGT
$7.1B
$6.65M 0.29%
852,855
+61,919
+8% +$617K
OPTN
65
DELISTED
OptiNose
OPTN
$6.59M 0.28%
986,031
+28,917
+3% +$255K
IMAX icon
66
CALL
IMAX
IMAX
$2.81B
$6.4M 0.27%
250,000
-1,250,000
-83% -$29.4M
NPCE icon
67
Neuropace
NPCE
$507M
$6.29M 0.27%
562,073
-45,817
-8% -$398K
STKS icon
68
The ONE Group
STKS
$56.5M
$6.05M 0.26%
2,087,394
+403,321
+24% +$1.34M
ATXS
69
DELISTED
Astria Therapeutics
ATXS
$6.03M 0.26%
675,000
– –
GPCR icon
70
Structure Therapeutics
GPCR
$3.82B
$5.99M 0.26%
221,000
+50,000
+29% +$1.77M
VTGN icon
71
VistaGen Therapeutics
VTGN
$11.7M
$5.85M 0.25%
1,981,980
+464,284
+31% +$1.31M
FOSL icon
72
Fossil Group
FOSL
$317M
$5.56M 0.24%
3,326,677
+1,421,399
+75% +$2.08M
ALTG icon
73
Alta Equipment Group
ALTG
$237M
$5.53M 0.24%
845,115
– –
AMLX icon
74
Amylyx Pharmaceuticals
AMLX
$2.53B
$5.49M 0.24%
1,452,153
+47,589
+3% +$224K
HLF icon
75
CALL
Herbalife
HLF
$1.21B
$5.35M 0.23%
800,000
– –
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Nantahala Capital Management held 157 positions worth $2.33B, up 18% from $1.98B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nantahala Capital Management deployed $348M of net new capital in Q4 2024, opening 17 new positions and adding to 46 existing holdings. Its largest new stake was Service Properties Trust: 1,618,380 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Establishment Labs, an estimated $30.7M trimmed.

  • Nantahala Capital Management's largest Q4 2024 buy was Service Properties Trust: 1,618,380 shares worth $20.6M.
  • Nantahala Capital Management added most to Hilton Grand Vacations in Q4 2024, an estimated $38.8M increase.
  • Nantahala Capital Management's biggest Q4 2024 reduction was Establishment Labs, cutting an estimated $30.7M.
  • Nantahala Capital Management fully exited PowerSchool Holdings, Inc. in Q4 2024, selling an estimated $13.3M.
  • Nantahala Capital Management's ten largest holdings make up 55% of its $2.33B portfolio in Q4 2024.
  • Nantahala Capital Management opened 17 new positions and closed 20 in Q4 2024.
  • Nantahala Capital Management's portfolio value rose 18% quarter-over-quarter to $2.33B.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.